Functional outcome of De Quervain’s tenosynovitis with longitudinal incision in surgically treated patients

  • H. J. Mangukiya
  • A. KaleEmail author
  • N. P. Mahajan
  • U. Ramteke
  • J. Manna
Original Article



De Quervain described tenosynovitis of first dorsal compartment more than 120 years ago. Women, particularly of 4th–5th decades, are at more risk of developing disease. Steroid injection has been described as first line of management over many decades, but it is associated with some significant complications like depigmentation of skin, atrophy of subcutaneous tissue, suppurative tenosynovitis and even tendon rupture. Animal studies have also reported increased risk of peritendinous adhesions with steroid injection.

Materials and methods

We prospectively managed 46 cases of De Quervain’s tenosynovitis with longitudinal incision at tertiary care hospital from 2014 to 2016. There were totally 40 patients with 9 males and 31 females between age group of 28 and 62 years. All patients were evaluated using DASH and VAS scores preoperatively and post-operatively.


The mean preoperative DASH score was 42.26 which reduced to 5.37 post-operatively. The mean preoperative VAS score was 7.30 which reduced to 2.33 post-operatively. Intraoperatively, we found peritendinous adhesions in 8 patients and ganglion arising from first dorsal compartment in one patient. Post-operatively, we found hypertrophic scar in 3 patients and persistent numbness to first dorsal web space due to injury to superficial radial nerve in 2 patients. Six patients had recurrent symptoms and required revision surgery.


Surgical release of De Quervain’s tenosynovitis remains the gold standard treatment, and longitudinal incision offers advantage of easy identification of compartment, more complete releases of tendon sheath and peritendinous adhesions and less risk of palmar subluxation of tendons.


De Quervain Surgery Longitudinal incision Functional outcome 


Compliance with ethical standards

Conflict of interest

There is no conflict of interest.

Human and animal rights

This article does not contain any studies with animals performed by any of the authors.

Informed consent

A well informed consent was taken from all patients participating in the study.


  1. 1.
    de Quervain F (2005) On a form of chronic tendovaginitis (Translated article: Cor-Bl.f.schweiz. Aerzrte 1895:25:389-94). J Hand Surg Br 30(4):388–391Google Scholar
  2. 2.
    Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C (2004) Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheumatol 51:642–651CrossRefGoogle Scholar
  3. 3.
    Johnson CA (1991) Occurrence of de Quervain disease in postpartum women. Fam Pract 32:325–327Google Scholar
  4. 4.
    Schned ES (1986) De Quervain tenosynovitis in pregnant and postpartum women. Obstet Gynecol 68:411–414CrossRefGoogle Scholar
  5. 5.
    Scand J (2011) Risk factors for de Quervain’s disease in a French working population. Work Environ Health 37(5):394–401CrossRefGoogle Scholar
  6. 6.
    Clarke MT, Lyall HA, Grant JW, Matthewson MH (1998) The histopathology of de Quervain’s disease. J Hand Surg Br 23(6):732–734CrossRefGoogle Scholar
  7. 7.
    Finkelstein H (1930) Stenosing tendovaginitis at the radial styloid process. J Bone Jt Surg 12A:509–540Google Scholar
  8. 8.
    Giovagnorio F, Andreoli C, De Cicco ML (1997) Ultrasonographic evaluation of de Quervain disease. J Ultrasound Med 16:685–689CrossRefGoogle Scholar
  9. 9.
    Jackson WT, Viegas SF, Coon TM et al (1986) Anatomical variations in the first extensor compartment of the wrist. J Bone Jt Surg Am 68:923–926CrossRefGoogle Scholar
  10. 10.
    Ilyas AM, Ast M, Schaffer AA, Thoder J (2007) De Quervain tenosynovitis of the wrist. J Am Acad Orthop Surg 15(12):757–764CrossRefGoogle Scholar
  11. 11.
    Jaworski CA, Krause M, Brown J (2010) Rehabilitation of the wrist and hand following sports injury. Clin Sports Med 29(1):61–80CrossRefGoogle Scholar
  12. 12.
    Robinson BS (2003) Rehabilitation of a cellist after surgery for de Quervain’s tenosynovitis and intersection syndrome. Med Probl Perform Artists 18(3):106–112Google Scholar
  13. 13.
    Hartzell TL, Rubenstein R, Herman M (2013) Therapeutic modalities—an updated review for the hand surgeon. J Hand Surg 37A:597–621Google Scholar
  14. 14.
    McKenzie JM (1972) Conservative treatment of de Quervain’s disease. Br Med J 4(5841):659–660CrossRefGoogle Scholar
  15. 15.
    Peters-Veluthamaningal C, van der Windt DA, Winters JC, Meyboom-de Jong B (2009) Corticosteroid injection for de Quervain’s tenosynovitis. Cochrane Database Syst Rev 8(3):CD005616Google Scholar
  16. 16.
    Kwon BC, Choi S-J, Koh SH, Shin DJ, Baek GH (2010) Sonographic identification of the intracompartmental septum in de Quervain’s disease. Clin Orthop Relat Res 468(8):2129–2134CrossRefGoogle Scholar
  17. 17.
    Witt J, Pess G, Gelberman RH (1991) Treatment of de Quervain tenosynovitis: a prospective study of the results of injection of steroids and immobilization in a splint. J Bone Jt Surg Am 73:219–222CrossRefGoogle Scholar
  18. 18.
    Zingas C, Failla JM, Van Holsbeeck M (1998) Injection accuracy and clinical relief of de Quervain’s tendinitis. J Hand Surg Am 23:89–96CrossRefGoogle Scholar
  19. 19.
    Sawaizumi T, Nanno M, Ito H (2007) De Quervain’s disease: efficacy of intra-sheath triamcinolone injection. Int Orthop 31(2):265–268CrossRefGoogle Scholar
  20. 20.
    Sampson SP, Wisch D, Badalamente MA (1994) Complications of conservative and surgical treatment of de Quervain’s disease and trigger fingers. Hand Clin 10(1):73–82PubMedGoogle Scholar
  21. 21.
    Tatari H, Koşay C, Baran Ö et al (2001) Deleterious effects of local corticosteroid injections on the Achilles tendon of rats. Arch Orthop Traum Surg 121:333CrossRefGoogle Scholar
  22. 22.
    Wong MWN, Tang YN, Fu S-C, Lee K, Chan KM (2004) Triamcinolone suppresses human tenocyte cellular activity and collagen synthesis. Clin Orthop Relat Res 421:277–281CrossRefGoogle Scholar
  23. 23.
    Froimson A (1993) Tenosynovitis and tennis elbow. In: Green DP (ed) Operative hand surgery, vol 2, 3rd edn. Churchill Livingstone, New York, pp 1989–2006Google Scholar
  24. 24.
    Lapidus PW, Fenton R (1952) Stenosing tenovaginitis at the wrist and fingers: report of 423 cases in 369 patients with 354 operations. Arch Surg 64:475–487CrossRefGoogle Scholar
  25. 25.
    Gundes H, Tosun B (2005) Longitudinal incision in surgical release of De Quervain disease. Tech Hand Up Extrem Surg 9(3):149–152CrossRefGoogle Scholar
  26. 26.
    Abrisham SJ, Karbasi MHA, Zare J, Behnamfar Z, Tafti AD, Shishesaz B (2011) De Qeurvian tenosynovitis: clinical outcomes of surgical treatment with longitudinal and transverse incision. Oman Med J 26(2):91–93CrossRefGoogle Scholar
  27. 27.
    Scheller A, Schuh R, Honle W, Schuh A (2009) Long-term results of surgical release of de Quervain’s stenosing tenosynovitis. Int Orthop 33(5):1301–1303CrossRefGoogle Scholar
  28. 28.
    Kumar K (2016) Outcome of longitudinal versus transverse incision in de Quervain’s disease and its implications in Indian population. Musculoskelet Surg 100:49CrossRefGoogle Scholar

Copyright information

© Istituto Ortopedico Rizzoli 2019

Authors and Affiliations

  • H. J. Mangukiya
    • 1
  • A. Kale
    • 1
    Email author
  • N. P. Mahajan
    • 2
  • U. Ramteke
    • 2
  • J. Manna
    • 2
  1. 1.Department of OrthopaedicsB.J Medical College and Sassoon General HospitalPuneIndia
  2. 2.Grant Govt Medical College and Sir J.J Group of HospitalMumbaiIndia

Personalised recommendations